Kiniksa Pharmaceuticals

Developer of therapeutics for multiple diseases treatment

placeLexington, Kentucky, United States calendar_todayFounded 2015 groups2 employees language kiniksa.com

Registered entities

Innovation

21 patent families (5 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace steady. Cited 2,707 times.

YearFilings
20171
20182
20193
20207
20215
20226
20239
20248
202513
20264

Social engagement

Social engagement: 32.8K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

10 investors on record; lead investors include Sofinnova Investments, Venrock, Fidelity Investments.

Investor typeCountShare
Venture capital440%
Private equity110%
Bank & private debt220%
Other / undisclosed330%

Hiring activity

Hires periodically

8 roles tracked across 3 of the last 12 months

6 May 2026 · Associate Director/ Director, Pricing & Contracting · Lexington

8 Feb 2026 · Clinical Sales Specialist - Rochester, MN · Rochester

8 Feb 2026 · Clinical Sales Specialist - Minneapolis · Minneapolis

8 Feb 2026 · Clinical Sales Specialist - San Jose · San Jose

7 Feb 2026 · Clinical Sales Specialist - Des Moines, IA · Des Moines

Based on job postings tracked across public sources.

Recent activity

29 May 2026
Event
2026 Jefferies Global Healthcare Conference
28 Apr 2026
Event
Live Webcast and conference call
28 Mar 2026
Event
Ciniksa-sponsored panel discussion and Q&A about Evidence-Based Strategies for the Treatment of Recurrent Pericarditis
Coming soon